4-Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide

Catalog No. :
ACAYLU014
CAS No. :
112885-41-3
Molecular Formula :
C21H25ClFN3O3
Molecular Weight :
421.90

IUPAC Name:4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide

4-Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g99%$111.00Login to see priceIn stockInquiry
100g99%$401.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide
IUPAC Name4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide
MDL No.MFCD00867430
Molecular FormulaC21H25ClFN3O3
Molecular Weight421.90
SMILESC1=C(C(=CC(=C1Cl)N)OCC)C(NCC3CN(CC2=CC=C(C=C2)F)CCO3)=O
InChI KeyYPELFRMCRYSPKZ-UHFFFAOYSA-N
SynonymTAK-370 | AS-4370 | Mosart (TN) | 4-Amino-5-chloro-2-ethoxy-N-[[4-(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide | 4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide | UNII-I8MFJ1C0BY | 4-amino-5-chloro-2-ethox
CAS No.112885-41-3
PubChem CID119584

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACAYLU014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAYLU014 route product structure diagram
    ACAYLU014112885-41-3 In Stock
Inquiry

2. ACAYLU014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAYLU014 route product structure diagram
    ACAYLU014112885-41-3 In Stock
Inquiry

Comments (0)